RetinalGenix Technologies Inc.
RTGN
$3.55
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 10.61% | -24.77% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.56% | -32.29% | |||
| Operating Income | -10.56% | 32.29% | |||
| Income Before Tax | -10.57% | 32.26% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -10.57% | 32.26% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -10.57% | 32.26% | |||
| EBIT | -10.56% | 32.29% | |||
| EBITDA | -10.57% | 32.30% | |||
| EPS Basic | -11.67% | 33.68% | |||
| Normalized Basic EPS | -11.62% | 33.78% | |||
| EPS Diluted | -11.67% | 33.68% | |||
| Normalized Diluted EPS | -11.62% | 33.78% | |||
| Average Basic Shares Outstanding | -1.06% | 2.06% | |||
| Average Diluted Shares Outstanding | -1.06% | 2.06% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||